Assignee
KEYTHERA SUZHOU PHARMACEUTICALS CO LTD
CN·1 granted patent·1 pending application·0 citations·filing 2019–2020
Top patents by PatentIndex Score
2 records- 0143US12240812B2Compound for inhibiting PGE2/EP4 signaling transduction inhibiting, preparation method therefor, and medical uses thereofKEYTHERA SUZHOU PHARMACEUTICALS CO LTD·Filed 2020·Granted Mar 4, 2025·0 cites·12 claims
- 0240US2022017520A1Macrocyclic compound as cdk inhibitor, preparation method therefor, and use thereof in medicineKEYTHERA SUZHOU PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KEYTHERA SUZHOU PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →